Diploma PLC (LON:DPLM)
4,260.00
+66.00 (1.57%)
May 13, 2025, 5:00 PM BST
Revenue by Product
Fiscal year is October - September.
Year Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
---|---|---|---|---|---|
Life Sciences | 221.90M |
Log In |
Log In |
Log In |
Log In |
Life Sciences Growth | 17.83% |
Log In |
Log In |
Log In |
Log In |
Seals | 489.10M |
Log In |
Log In |
Log In |
Log In |
Seals Growth | 52.60% |
Log In |
Log In |
Log In |
Log In |
Controls | 652.40M |
Log In |
Log In |
Log In |
Log In |
Controls Growth | 46.01% |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is October - September.
Year Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
---|---|---|---|---|---|
Life Sciences Operating Profit | 35.30M |
Log In |
Log In |
Log In |
Log In |
Life Sciences Operating Profit Growth | -11.59% |
Log In |
Log In |
Log In |
Log In |
Seals Operating Profit | 62.20M |
Log In |
Log In |
Log In |
Log In |
Seals Operating Profit Growth | 42.51% |
Log In |
Log In |
Log In |
Log In |
Controls Operating Profit | 132.30M |
Log In |
Log In |
Log In |
Log In |
Controls Operating Profit Growth | 108.50% |
Log In |
Log In |
Log In |
Log In |
Corporate Operating Profit | -22.40M |
Log In |
Log In |
Log In |
Log In |
Corporate Operating Profit Growth | 34.35% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is October - September.
Year Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
---|---|---|---|---|---|
United Kingdom | 273.00M |
Log In |
Log In |
Log In |
Log In |
United Kingdom Growth | 53.35% |
Log In |
Log In |
Log In |
Log In |
Rest of Europe | 267.80M |
Log In |
Log In |
Log In |
Log In |
Rest of Europe Growth | 43.49% |
Log In |
Log In |
Log In |
Log In |
North America | - |
Log In |
Log In |
Log In |
Log In |
North America Growth | - |
Log In |
Log In |
Log In |
Log In |
Rest of World Revenue (Pre-FY2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In |
Rest of World Revenue (Pre-FY2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In |
USA | 626.10M |
Log In |
Log In |
Log In |
Log In |
USA Growth | - |
Log In |
Log In |
Log In |
Log In |
Rest of World | 196.50M |
Log In |
Log In |
Log In |
Log In |
Rest of World Growth | - |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is October - September.
Year Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
---|---|---|---|---|---|
United Kingdom Adjusted Operating Profit | 23.30M |
Log In |
Log In |
Log In |
Log In |
United Kingdom Adjusted Operating Profit Growth | -38.96% |
Log In |
Log In |
Log In |
Log In |
Rest of Europe Adjusted Operating Profit | 53.90M |
Log In |
Log In |
Log In |
Log In |
Rest of Europe Adjusted Operating Profit Growth | 110.79% |
Log In |
Log In |
Log In |
Log In |
North America Adjusted Operating Profit | - |
Log In |
Log In |
Log In |
Log In |
North America Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In |
Rest of World Adjusted Operating Profit (Pre-FY2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In |
Rest of World Adjusted Operating Profit (Pre-FY2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In |
USA Adjusted Operating Profit | 165.50M |
Log In |
Log In |
Log In |
Log In |
USA Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In |
Rest of World Adjusted Operating Profit | 42.30M |
Log In |
Log In |
Log In |
Log In |
Rest of World Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In |
Life Sciences Adjusted Operating Profit | 46.80M |
Log In |
Log In |
Log In |
Log In |
Life Sciences Adjusted Operating Profit Growth | 17.76% |
Log In |
Log In |
Log In |
Log In |
Seals Adjusted Operating Profit | 87.10M |
Log In |
Log In |
Log In |
Log In |
Seals Adjusted Operating Profit Growth | 16.30% |
Log In |
Log In |
Log In |
Log In |
Controls Adjusted Operating Profit | 144.00M |
Log In |
Log In |
Log In |
Log In |
Controls Adjusted Operating Profit Growth | 26.02% |
Log In |
Log In |
Log In |
Log In |
Corporate Adjusted Operating Profit | -22.40M |
Log In |
Log In |
Log In |
Log In |
Corporate Adjusted Operating Profit Growth | 44.58% |
Log In |
Log In |
Log In |
Log In |
Life Sciences Organic Growth | 6.00% |
Log In |
Log In |
Log In |
Log In |
Seals Organic Growth | 1.00% |
Log In |
Log In |
Log In |
Log In |
Controls Organic Growth | 10.00% |
Log In |
Log In |
Log In |
Log In |
Group Organic Growth | 6.00% |
Log In |
Log In |
Log In |
Log In |